* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
JSC Georgia Healthcare Group is the healthcare-services (hospitals and clinics) business of Georgia Capital PLC (LSE: CGEO) — Georgia's largest integrated healthcare provider. It was established in Georgia Capital's 2024 reorganization to hold the hospital/clinic operations carved out of the former GHG (e.g. JSC Georgian Clinics, JSC Viani), while the pharmacy business stayed with the renamed Georgia Pharmacy Group (id 405098399). It runs about 7 large and specialty hospitals, ~30 regional and community hospitals, 16 EVEX polyclinics and the Mega Lab diagnostics laboratory (~2,460 beds), and acquired Gormed LLC (three regional hospitals and clinics) in December 2025. The GHG healthcare business was LSE-listed until Georgia Capital took it private in August 2020.
| Line item | 2024 |
|---|---|
| Net Cash from Operating Activities | 69,955 |
| Net Cash used in Investing Activities | 31,718 |
| Free Cash Flow (OCF − Capex proxy) | 38,237 |
| Net Cash from Financing Activities | 33,226 |
| Net Change in Cash (before FX) | 5,011 |
| Effect of FX on Cash | 498 |
| Net Change in Cash (incl. FX) | 4,513 |
| Cash at Beginning of Year | 34,271 |
| Cash at End of Year | 38,784 |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →